Skip to main content
Top
Published in: World Journal of Surgery 6/2005

01-06-2005

Clinical Significance of Occult Metastatic Melanoma in Sentinel Lymph Nodes and Other High-risk Factors Based on Long-term Follow-up

Authors: Stanley P.L. Leong, M.D., Mohammed Kashani-Sabet, M.D., Renee A. Desmond, Ph.D., Robert P. Kim, M.D., Dennis H. Nguyen, B.A., Kensho Iwanaga, B.A., Patrick A. Treseler, M.D., Ph.D., Robert E. Allen Jr., M.D., Eugene T. Morita, M.D., Yuting Zhang, M.S., Richard W. Sagebiel, M.D., Seng-Jaw Soong, Ph.D.

Published in: World Journal of Surgery | Issue 6/2005

Login to get access

Abstract

Selective sentinel lymphadenectomy (SSL) following preoperative lymphoscintigraphy is the most significant recent advance in the management of patients with primary melanoma. This study evaluates the prognostic value of sentinel lymph node (SLN) status and other risk factors in predicting survival and recurrence in patients with primary cutaneous melanoma. From October 1993 to July 1998 a series of 412 patients with primary invasive melanoma underwent SSL at the UCSF/ Mt. Zion Melanoma Center. The outcome of 363 evaluable patients is summarized in this study. The factors related to survival and disease recurrence were analyzed by Cox proportional hazard regression models. The overall incidence of patients with positive SLNs was 18%. Over a median follow-up of 4.8 years, the overall mortality rate in patients with primary cutaneous melanoma was 18.7%, and 74 recurrences occurred (20.4%). Mortality was significantly related to SLN status [HR = 2.06; 95% Confidence interval (CI) 1.18, 3.58], angiolymphatic invasion (HR = 2.21; 95% CI 1.08, 4.55), ulceration (HR = 1.79; 95% CI 1.02, 3.15), mitotic index (HR =1.38; 95% CI 1.01, 1.90), and tumor thickness (HR = 2.20, 95% CI 1.21, 3.99). Factors significantly related to disease-free survival included SLN status (HR = 2.09; 95% CI 1.31, 3.34), tumor thickness (HR = 1.89; 95%. CI 1.20,2.98), and age (HR= 1.26 95% CI 1.08, 1.47). SLN status was the most significant factor for melanoma recurrence and death. Other important predictors include tumor thickness, ulceration, lymphatic invasion, and mitotic index.
Literature
1.
go back to reference Morton, DL, Wen, DR, Wong, JH, et al. 1992Technical details of intraoperative lymphatic mapping for early stage melanomaArch. Surg.9:127392 Morton, DL, Wen, DR, Wong, JH,  et al. 1992Technical details of intraoperative lymphatic mapping for early stage melanomaArch. Surg.9:127392
2.
go back to reference Reintgen, DS, Cruse, CW, Wells, K 1994The orderly progression of melanoma nodal metastasesAnn. Surg.67759767 Reintgen, DS, Cruse, CW, Wells, K 1994The orderly progression of melanoma nodal metastasesAnn. Surg.67759767
3.
go back to reference Albertini, JJ, Cruse, CW, Rapaport, D, et al. 1996Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanomaAnn. Surg.223217224CrossRefPubMed Albertini, JJ, Cruse, CW, Rapaport, D,  et al. 1996Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanomaAnn. Surg.223217224CrossRefPubMed
4.
go back to reference Krag, DN, Meijer, SJ, Weaver, DL, et al. 1995Minimal-access surgery for staging of malignant melanomaArch. Surg.8654658 Krag, DN, Meijer, SJ, Weaver, DL,  et al. 1995Minimal-access surgery for staging of malignant melanomaArch. Surg.8654658
5.
go back to reference Ross, MI, Reintgen, DS, Balch, CM 1993Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanomaSemin. Surg. Oncol.9219223PubMed Ross, MI, Reintgen, DS, Balch, CM 1993Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanomaSemin. Surg. Oncol.9219223PubMed
6.
go back to reference Thompson, JF, McCarthy, WH, Bosch, CM, et al. 1995Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodesMelanoma Res.5255260PubMed Thompson, JF, McCarthy, WH, Bosch, CM,  et al. 1995Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodesMelanoma Res.5255260PubMed
7.
go back to reference Morton, DL, Chan, AD 1999Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?J. Am. Coll. Surg.189214223CrossRefPubMed Morton, DL, Chan, AD 1999Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care?J. Am. Coll. Surg.189214223CrossRefPubMed
8.
go back to reference Leong, SPL 2004Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanomaCurr. Treat. Options Oncol.5185194PubMed Leong, SPL 2004Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanomaCurr. Treat. Options Oncol.5185194PubMed
9.
go back to reference Norman, J, Cruse, C, Espinosa, C, et al. 1991Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanomaAm. J. Surg.162432437CrossRefPubMed Norman, J, Cruse, C, Espinosa, C,  et al. 1991Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanomaAm. J. Surg.162432437CrossRefPubMed
10.
go back to reference Thompson, J, Uren, R, Shaw, H, et al. 1999Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomyJ. Am. Coll. Surg.189195206CrossRefPubMed Thompson, J, Uren, R, Shaw, H,  et al. 1999Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomyJ. Am. Coll. Surg.189195206CrossRefPubMed
11.
go back to reference Leong, SPL, Achtem, TA, Habib, FA, et al. 1999Discordancy between clinical predictions versus lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanomaArch. Dermatol.13514721476CrossRefPubMed Leong, SPL, Achtem, TA, Habib, FA,  et al. 1999Discordancy between clinical predictions versus lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanomaArch. Dermatol.13514721476CrossRefPubMed
12.
go back to reference McMasters, KM, Wong, SL, Edwards, MJ, et al. 2001Factors that predict the presence of sentinel lymph node metastasis in patients with melanomaSurgery130151156CrossRefPubMed McMasters, KM, Wong, SL, Edwards, MJ,  et al. 2001Factors that predict the presence of sentinel lymph node metastasis in patients with melanomaSurgery130151156CrossRefPubMed
13.
go back to reference Cherpelis, BS, Haddad, F, Messina, J, et al. 2001Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomasJ. Am. Acad. Dermatol.44762766CrossRefPubMed Cherpelis, BS, Haddad, F, Messina, J,  et al. 2001Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomasJ. Am. Acad. Dermatol.44762766CrossRefPubMed
14.
go back to reference Gershenwald, JE, Thompson, W, Mansfield, PF, et al. 1999Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patientsJ. Clin. Oncol.17976983PubMed Gershenwald, JE, Thompson, W, Mansfield, PF,  et al. 1999Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patientsJ. Clin. Oncol.17976983PubMed
15.
go back to reference Statius Muller, MG, Leeuwen, PA, Lange-De Klerk, ES, et al. 2001The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanomaCancer9124012408CrossRefPubMed Statius Muller, MG, Leeuwen, PA, Lange-De Klerk, ES,  et al. 2001The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanomaCancer9124012408CrossRefPubMed
16.
go back to reference Clary, BM, Mann, B, Brady, MS, et al. 2001Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissectionAnn-Surg.Oncol.8328337PubMed Clary, BM, Mann, B, Brady, MS,  et al. 2001Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissectionAnn-Surg.Oncol.8328337PubMed
17.
go back to reference Essner, R, Conforti, A, Kelley, MC, et al. 1999Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanomaAnn. Surg. Oncol.6442449CrossRefPubMed Essner, R, Conforti, A, Kelley, MC,  et al. 1999Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanomaAnn. Surg. Oncol.6442449CrossRefPubMed
18.
go back to reference Gadd, MA, Cosimi, AB, Yu, J, et al. 1999Outcome of patients with melanoma and histologically negative sentinel lymph nodesArch. Surg.134381387CrossRefPubMed Gadd, MA, Cosimi, AB, Yu, J,  et al. 1999Outcome of patients with melanoma and histologically negative sentinel lymph nodesArch. Surg.134381387CrossRefPubMed
19.
go back to reference Sondergaard, K 1985Depth of invasion and tumor thickness in primary cutaneous malignant melanoma: a study of 2012 casesActa Pathol Microbiol. Immunol. Scand. [A]934955 Sondergaard, K 1985Depth of invasion and tumor thickness in primary cutaneous malignant melanoma: a study of 2012 casesActa Pathol Microbiol. Immunol. Scand. [A]934955
20.
go back to reference Balch, CM, Murad, TM, Soong, S-J, et al. 1978A multifactorial analysis of melanoma: prognostic histopathologic features comparing Clark’s and Breslow’s staging methodsAnn. Surg.188732742PubMed Balch, CM, Murad, TM, Soong, S-J,  et al. 1978A multifactorial analysis of melanoma: prognostic histopathologic features comparing Clark’s and Breslow’s staging methodsAnn. Surg.188732742PubMed
21.
go back to reference Balch, CM, Soong, S-J, Murad, TM, et al. 1979A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanomaSurgery86343PubMed Balch, CM, Soong, S-J, Murad, TM,  et al. 1979A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanomaSurgery86343PubMed
22.
go back to reference Buzaid, AC, Ross, MI, Balch, CM, et al. 1977Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemJ. Clin. Oncol.1510391051 Buzaid, AC, Ross, MI, Balch, CM,  et al. 1977Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging systemJ. Clin. Oncol.1510391051
23.
go back to reference Morton, DL, Davtyan, DG, Wanek, LA, et al. 1993Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thicknessCancer7137373743PubMed Morton, DL, Davtyan, DG, Wanek, LA,  et al. 1993Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thicknessCancer7137373743PubMed
24.
go back to reference Mraz-Gernhard, S, Sagebiel, RW, Kashani-Sabet, M, et al. 1998Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanomaArch. Dermatol.134983987CrossRefPubMed Mraz-Gernhard, S, Sagebiel, RW, Kashani-Sabet, M,  et al. 1998Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanomaArch. Dermatol.134983987CrossRefPubMed
25.
go back to reference Leong, SPL, Steinmetz, I, Habib, F, et al. 1997Optimal selective sentinel lymph node dissection in primary malignant melanomaArch. Surg.132666673PubMed Leong, SPL, Steinmetz, I, Habib, F,  et al. 1997Optimal selective sentinel lymph node dissection in primary malignant melanomaArch. Surg.132666673PubMed
26.
go back to reference Treseler, PA, Tauchi, PS 2000Pathologic analysis of the sentinel lymph nodeSurg. Clin North Am.8016951719CrossRefPubMed Treseler, PA, Tauchi, PS 2000Pathologic analysis of the sentinel lymph nodeSurg. Clin North Am.8016951719CrossRefPubMed
27.
go back to reference Balch, CM, Buzaid, AC, Soong, S, et al. 2001Final version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJ. Clin. Oncol.1935353648 Balch, CM, Buzaid, AC, Soong, S,  et al. 2001Final version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJ. Clin. Oncol.1935353648
28.
go back to reference Wagner, JD, Ranieri, J, Evdokimow, DZ, et al. 2003Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphodenectomy for melanomaPlast. Reconstr. Surg.12486497CrossRef Wagner, JD, Ranieri, J, Evdokimow, DZ,  et al. 2003Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphodenectomy for melanomaPlast. Reconstr. Surg.12486497CrossRef
29.
go back to reference Leong SPL, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma to sentinel lymph nodes and other high risk factors based on a long-term follow-up. World J. Surg. 2005;29:in press Leong SPL, Kashani-Sabet M, Desmond RA, et al. Clinical significance of occult metastatic melanoma to sentinel lymph nodes and other high risk factors based on a long-term follow-up. World J. Surg. 2005;29:in press
30.
go back to reference Coit, DG, Rogatko, A, Brennan, MF 1991Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: a multivariate analysisAnn. Surg.214627636PubMed Coit, DG, Rogatko, A, Brennan, MF 1991Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes: a multivariate analysisAnn. Surg.214627636PubMed
31.
go back to reference Day, CL, Lew, RA, Mihm, MC, et al. 1981The natural break points for primary-tumor thickness in clinical stage I melanomaN. Engl. J. Med.3051155 Day, CL, Lew, RA, Mihm, MC,  et al. 1981The natural break points for primary-tumor thickness in clinical stage I melanomaN. Engl. J. Med.3051155
32.
go back to reference Karakousis, CP, Emrich, LJ, Rao, U 1989Tumor thickness and prognosis in clinical stage I malignant melanomaCancer6414321436PubMed Karakousis, CP, Emrich, LJ, Rao, U 1989Tumor thickness and prognosis in clinical stage I malignant melanomaCancer6414321436PubMed
33.
go back to reference Kashani-Sabet, M, Sagebiel, RW, Ferreira, CM, et al. 2001Vascular involvement in the prognosis of primary cutaneous melanomaArch. Dermatol.13711691173PubMed Kashani-Sabet, M, Sagebiel, RW, Ferreira, CM,  et al. 2001Vascular involvement in the prognosis of primary cutaneous melanomaArch. Dermatol.13711691173PubMed
34.
go back to reference Gershenwald, JE, Colome, MI, Lee, JE, et al. 1998Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanomaJ. Clin. Oncol.1622532260PubMed Gershenwald, JE, Colome, MI, Lee, JE,  et al. 1998Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanomaJ. Clin. Oncol.1622532260PubMed
35.
go back to reference Robert, M, Wen, D, Cochran, A 1993Pathological evaluation of the regional lymph nodes in malignant melanomaSemin. Diagn. Pathol.10102115PubMed Robert, M, Wen, D, Cochran, A 1993Pathological evaluation of the regional lymph nodes in malignant melanomaSemin. Diagn. Pathol.10102115PubMed
36.
go back to reference Messina, JL, Glass, LF 1997Pathologic examination of the sentinel lymph nodeJ. Fla. Med. Assoc.84153156PubMed Messina, JL, Glass, LF 1997Pathologic examination of the sentinel lymph nodeJ. Fla. Med. Assoc.84153156PubMed
37.
go back to reference Heller, R, Becker, J, Wasselle, J, et al. 1992Detection of occult lymph node metastases in malignant melanomaAnn. Plast. Surg.287477PubMed Heller, R, Becker, J, Wasselle, J,  et al. 1992Detection of occult lymph node metastases in malignant melanomaAnn. Plast. Surg.287477PubMed
38.
go back to reference Wang, X, Heller, R, VanVoorheis, N, et al. 1994Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanomaAnn. Surg.220768774PubMed Wang, X, Heller, R, VanVoorheis, N,  et al. 1994Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanomaAnn. Surg.220768774PubMed
39.
go back to reference Shivers, SC, Wang, X, Li, W, et al. 1998Molecular staging of malignant melanoma: correlation with clinical outcomeJ.A.M.A.28014101415PubMed Shivers, SC, Wang, X, Li, W,  et al. 1998Molecular staging of malignant melanoma: correlation with clinical outcomeJ.A.M.A.28014101415PubMed
40.
go back to reference Carson, KF, Wen, DR, Li, PX, et al. 1996Nodal nevi and cutaneous melanomasAm. J. Surg. Pathol.20834840CrossRefPubMed Carson, KF, Wen, DR, Li, PX,  et al. 1996Nodal nevi and cutaneous melanomasAm. J. Surg. Pathol.20834840CrossRefPubMed
41.
go back to reference Biddle, DA 2003Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinomaAm. J. Surg. Pathol.27673681CrossRefPubMed Biddle, DA 2003Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinomaAm. J. Surg. Pathol.27673681CrossRefPubMed
42.
go back to reference Bostick, P, Morton, DL, Turner, RR, et al. 1999Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patientsJ. Clin. Oncol.1732383244PubMed Bostick, P, Morton, DL, Turner, RR,  et al. 1999Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patientsJ. Clin. Oncol.1732383244PubMed
43.
go back to reference Morton, DL, Hoon, DS, Cochran, AJ, et al. 2003Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastasesAnn. Surg.238538550PubMed Morton, DL, Hoon, DS, Cochran, AJ,  et al. 2003Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastasesAnn. Surg.238538550PubMed
44.
go back to reference Takeuchi, H, Morton, DL, Kuo, C, et al. 2004Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patientsJ. Clin. Oncol.2226712680CrossRefPubMed Takeuchi, H, Morton, DL, Kuo, C,  et al. 2004Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patientsJ. Clin. Oncol.2226712680CrossRefPubMed
Metadata
Title
Clinical Significance of Occult Metastatic Melanoma in Sentinel Lymph Nodes and Other High-risk Factors Based on Long-term Follow-up
Authors
Stanley P.L. Leong, M.D.
Mohammed Kashani-Sabet, M.D.
Renee A. Desmond, Ph.D.
Robert P. Kim, M.D.
Dennis H. Nguyen, B.A.
Kensho Iwanaga, B.A.
Patrick A. Treseler, M.D., Ph.D.
Robert E. Allen Jr., M.D.
Eugene T. Morita, M.D.
Yuting Zhang, M.S.
Richard W. Sagebiel, M.D.
Seng-Jaw Soong, Ph.D.
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 6/2005
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-7736-x

Other articles of this Issue 6/2005

World Journal of Surgery 6/2005 Go to the issue

OriginalPaper

To the Editor